Journal articleJ Clin Oncol2023
Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline.
- Journal
- J Clin Oncol
- Published
- 29 September 2023
- Citations
- 91
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Purpose To develop recommendations for systemic therapy for well-differentiated grade 1 (G1) to grade 3 (G3) metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Methods ASCO convened an Expert Panel to conduct a systematic review of relevant studies and develop recommendations for clinical practice. … Excerpt only: this text is the publisher’s. Read it in full at the source.